Navigation Links
Pulmo BioTech Inc. Announces Fund Raising Agreement with Moody Capital Solutions, Inc.
Date:6/15/2009

ed hospital and educational facility). Jointly owned by MHI subsidiary Innovacor as the technical and operational partner, Dr. Jocelyn Dupuis (the scientific director and originator of the PulmoBind Molecular Imaging technology), and by Pulmo BioTech Inc. as the funding partner, PulmoScience Inc. aims to develop this unique and exciting technology, to fund necessary trials, and to bring the products to market.

PulmoScience believes that the market for its product candidates is worth in excess of $500 million per annum and that, provided Regulatory Approval is achieved, the safety and efficacy of its products could allow it to dominate that market.

About PulmoBind

PulmoBind uses an intravenously delivered radionuclide tagged molecule which specifically bonds to the inner walls of the circulatory system in the lungs, and by the use of an external Gamma Camera allows an image of the integrity of the blood vessels throughout the lungs to be seen by a diagnostic clinician. PulmoScience is currently undertaking Regulatory Approval for Phase I Human Trials, and while subsequent results from additional tests might not corroborate the current results, PulmoScience believes that PulmoBind has the potential to dominate the market for the diagnosis of Pulmonary Embolism. In particular, this belief is driven by PulmoScience's expectations of the improved safety and efficacy that PulmoBind will offer when compared to the current incumbent nuclear medicine based technology for the diagnosis of Pulmonary Embolism. In addition, early indications are that PulmoBind could be highly effective in the early stage diagnosis of Pulmonary Hypertension, a condition for which there is no current front line diagnostic test. The addressable market for the product candidates being developed by PulmoScience is believed by the company to be worth in excess of $500 million per annum.

Further Information

For furthe
'/>"/>

SOURCE Pulmo BioTech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
2. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
3. Nuclear medicine approach can be first choice for excluding pulmonary embolism in young women
4. Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House
5. Deep Breeze Ltd. Launches Unique Non-Invasive, Radiation-Free Pulmonary Imaging System in the U.S.
6. Coalition for Pulmonary Fibrosis Fundraising Events Raise $280,000 for IPF
7. Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint
8. A new method allows for the early diagnosis of pulmonary hypertension
9. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
10. Free Program Dec. 1 to Help Patients With Debilitating Pulmonary Disorder Alpha-1
11. Evel Knievel Lost to Pulmonary Fibrosis; Disease Claims as Many Lives as Breast Cancer Each Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Over 20,000 entrepreneurs from around the world will ... | SHOP.COM International Convention at the Greensboro Coliseum on ... introduce new products, technology, programs and initiatives aimed at ... a who’s who of celebrities. , The event ... successful entrepreneurs and celebrity guests. Previous events have been ...
(Date:8/1/2014)... 01, 2014 Narrow networks that ... and employers effective options to trim pharmacy costs ... that they can enhance formulary compliance and achieve ... report that nearly all PBMs now include a ... proposals. The Aug. 12 webinar from Atlantic ...
(Date:8/1/2014)... 2014 Online retailer Disposable Medical Express ... price guarantee on their inventory of Tranquility incontinence care ... and pads along with other personal care products. ... find a line of incontinence products that you love,” ... that works for you, you shouldn't have to compromise ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Surftech athletes ... 2 Oahu paddleboard World Championships this past weekend in ... and 3rd place finisher Zeb Walsh were all on ... running of the race and athletes this year were ... wind making the course extremely challenging as well as ...
(Date:8/1/2014)... New York, US (PRWEB) August 01, 2014 ... 2013 was one of the most active years on record ... venture investment in life sciences represented 22 percent of all ... some big exits and achieved high valuations. , However, ... According to a recent report by Silicon Valley Bank, while ...
Breaking Medicine News(10 mins):Health News:Market America | SHOP.COM Set to Unveil Technology Enhancements and New Products at the 2014 International Convention 2Health News:Market America | SHOP.COM Set to Unveil Technology Enhancements and New Products at the 2014 International Convention 3Health News:Market America | SHOP.COM Set to Unveil Technology Enhancements and New Products at the 2014 International Convention 4Health News:Market America | SHOP.COM Set to Unveil Technology Enhancements and New Products at the 2014 International Convention 5Health News:Atlantic Information Services Webinar to Offer Health Plan, Employer Strategies for Implementing Narrow Pharma Networks 2Health News:Disposable Medical Express Offering Low Price Guarantee On Tranquility Products 2Health News:Surftech Bark Commander Sweeps Molokai2Oahu Stock Paddleboard Division 2Health News:Register to Join the Merrill DataSite's Webinar - Built to Sell: The Life Sciences Deal Climate 2Health News:Register to Join the Merrill DataSite's Webinar - Built to Sell: The Life Sciences Deal Climate 3
... H1N1 flu in these two groups, , WEDNESDAY, Dec. 23 ... by the pandemic H1N1 flu, two new studies confirm. , ... the New England Journal of Medicine . , "H1N1 ... Ken August, a spokesman for the California Department of Public ...
... a new target for prevention and treatment , WEDNESDAY, Dec. ... blood levels of the fat-carrying molecule called lipoprotein(a) can cause ... cause of coronary artery disease is now firm," said Martin ... Oxford in England and senior author of a report in ...
... likelihood of death rises with age, study finds ... approximately 2 million older adults who undergo common ... than others of suffering complications and early death, ... specific risks facing people 65 and older, the ...
... 23 As we try to get outside and make the ... safety tips that help minimize injury. The Minnesota Chiropractic Association (MCA) ... , -- Everything you wanted to know about shoveling but were ... system. If you must shovel, be careful and layer your clothing ...
... BALA CYNWYD, Pa., Dec. 23 Philadelphia Insurance Companies ... Chiropractor,s Malpractice Insurance in several states. Chiropractors may ... South Dakota and Utah. Filing approval is anticipated ... days with additional states to follow in 2010. , ...
... , WASHINGTON, Dec. 23 With the House having passed ... on the verge of passing its version (H.R. 3590), the outline ... new Issue Brief , The Concord Coalition looks ahead at ... committee discussions and "end game" negotiations. These include the cost of ...
Cached Medicine News:Health News: Swine Flu Hits Pregnant Women, Kids Hardest 2Health News: Swine Flu Hits Pregnant Women, Kids Hardest 3Health News:High Lipoprotein Levels Can Cause Heart Disease 2Health News:High Lipoprotein Levels Can Cause Heart Disease 3Health News:Post-Surgical Risks Highest in Older Adults 2Health News:WINTER SAFETY: Does the Body Good 2Health News:Philadelphia Insurance Companies Introduces Chiropractor Professional Liability Product 2Health News:New Concord Coalition Paper Discusses 'End Game' Fiscal Considerations for Health Care Reform 2
(Date:7/31/2014)... MUMBAI , Indien, August 1, 2014 ... ("Cipla") und BioQuiddity Inc. gaben heute bekannt, ... in regionalen Anästhesieanwendungen zur Schmerzbehandlung nach chirurgischen ... die das Gebiet der Europäischen Union und ... mit CE-Kennzeichnung versehene und mit Ropivacain gefüllte ...
(Date:7/31/2014)... IRIDEX Corporation (Nasdaq: IRIX ) today reported financial ... 28, 2014.  , Revenues were $10.6 million in ... in the 2013 second quarter and up sequentially from $10.3 ... first six months of 2014 were $20.9 million, up 15% ... year. , Gross margin for the quarter was 50.0%, ...
(Date:7/31/2014)... 2014 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... the quarter ended June 30, 2014. Financial Results ... Revenue Total revenue for the quarter ended June 30, ... quarter ended June 30, 2013 primarily due to IMBRUVICA ® ... Total revenue for the six months ended June 30, ...
Breaking Medicine Technology:Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 2Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 3IRIDEX Reports 2014 Second Quarter, Six-Month Results 2IRIDEX Reports 2014 Second Quarter, Six-Month Results 3IRIDEX Reports 2014 Second Quarter, Six-Month Results 4IRIDEX Reports 2014 Second Quarter, Six-Month Results 5IRIDEX Reports 2014 Second Quarter, Six-Month Results 6IRIDEX Reports 2014 Second Quarter, Six-Month Results 7Pharmacyclics Reports Second Quarter 2014 Results 2Pharmacyclics Reports Second Quarter 2014 Results 3Pharmacyclics Reports Second Quarter 2014 Results 4Pharmacyclics Reports Second Quarter 2014 Results 5Pharmacyclics Reports Second Quarter 2014 Results 6Pharmacyclics Reports Second Quarter 2014 Results 7Pharmacyclics Reports Second Quarter 2014 Results 8Pharmacyclics Reports Second Quarter 2014 Results 9Pharmacyclics Reports Second Quarter 2014 Results 10Pharmacyclics Reports Second Quarter 2014 Results 11Pharmacyclics Reports Second Quarter 2014 Results 12Pharmacyclics Reports Second Quarter 2014 Results 13Pharmacyclics Reports Second Quarter 2014 Results 14Pharmacyclics Reports Second Quarter 2014 Results 15Pharmacyclics Reports Second Quarter 2014 Results 16Pharmacyclics Reports Second Quarter 2014 Results 17Pharmacyclics Reports Second Quarter 2014 Results 18Pharmacyclics Reports Second Quarter 2014 Results 19Pharmacyclics Reports Second Quarter 2014 Results 20Pharmacyclics Reports Second Quarter 2014 Results 21Pharmacyclics Reports Second Quarter 2014 Results 22Pharmacyclics Reports Second Quarter 2014 Results 23Pharmacyclics Reports Second Quarter 2014 Results 24Pharmacyclics Reports Second Quarter 2014 Results 25Pharmacyclics Reports Second Quarter 2014 Results 26Pharmacyclics Reports Second Quarter 2014 Results 27Pharmacyclics Reports Second Quarter 2014 Results 28
... 27 Global pharmaceutical outsourcing has become ... supply chain environment that has pharmaceutical and life sciences ... co-sponsored by PwC US and published today by Axendia, ... the report, 50 percent of pharmaceutical and life sciences ...
... Essential Pharmaceuticals, LLC, a private company dedicated to ... sciences market, announced today that the Company will ... products: serum replacement, cryopreservation and clinical pathology media, ... Cell-Ess™ Serum Replacement cell culture medium, ...
Cached Medicine Technology:As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed 2As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed 3As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed 4As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed 5Essential Pharmaceuticals Acquires Exclusive Worldwide Rights to Family of Cell Media Products from Lifeblood Medical 2
... wall stand and table configurations designed for ... Canon CXDI-40G can capture 17 X 17 ... angle. This flexible system includes a Bucky ... and a ceiling suspended multi-positioning unit. Versatile ...
The Oscor PACE 203 H is the third generation of Osypka line of External Dual Chamber Pacemakers. Based on over 20 years of pacing experience, the PACE 203 H represents todays standard in temporary du...
... Oscors proprietary quadripolar pacing wire ... pacing and sensing in the ... two bipolar wires in one ... the atrium and ventricle are ...
... The TME 227 T is ... for temporary cardiac pacing and ... surgery. The TME 227 T ... the myocardium, which allows safe ...
Medicine Products: